Evidence map›Paper›PMID 40133256›Full record

ArticleNature communications2025

The ER-phagy receptor FAM134B is targeted by Salmonella Typhimurium to promote infection.

Damián Gatica, Reham M Alsaadi, Rayan El Hamra, Boran Li, Rudolf Mueller, Makoto Miyazaki, Qiming Sun, Subash Sad, Ryan C Russell

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Molecular strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  9. Autophagy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Damián Gatica *Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0001-5052-3131
Reham M Alsaadi *Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Rayan El HamraDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Boran LiInternational Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
Rudolf MuellerDepartment of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Makoto MiyazakiDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
Qiming SunInternational Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China.ORCID http://orcid.org/0000-0003-4988-9886
Subash SadDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0002-2462-7137
Ryan C RussellDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. ryan.russell@uottawa.ca.ORCID http://orcid.org/0000-0003-3364-8869

Funding

The role of MLKL in the regulation of vascular calcification in CKDR01HL132318 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MIYAZAKI, MAKOTO · 2016 to 2025
$3.8M
The transcriptional control of vascular calcification in diseaseR01HL157064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Makoto Miyazaki · 2023 to 2026
$2.5M
A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKDR01DK124901 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BLAINE, JUDITH T.,, MIYAZAKI, MAKOTO · 2021 to 2024
$1.9M
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 153034Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 376756National Natural Science Foundation of China (National Science Foundation of China) 32025012National Natural Science Foundation of China (National Science Foundation of China) 92254307NHLBI NIH HHS R01 HL132318NHLBI NIH HHS R01 HL157064NIDDK NIH HHS R01 DK124901
6 · The paper itself

Abstract

Macroautophagy/autophagy is a key catabolic-recycling pathway that can selectively target damaged organelles or invading pathogens for degradation. The selective autophagic degradation of the endoplasmic reticulum (hereafter referred to as ER-phagy) is a homeostatic mechanism, controlling ER size, the removal of misfolded protein aggregates, and organelle damage. ER-phagy can also be stimulated by pathogen infection. However, the link between ER-phagy and bacterial infection remains poorly understood, as are the mechanisms evolved by pathogens to escape the effects of ER-phagy. Here, we show that Salmonella enterica serovar Typhimurium inhibits ER-phagy by targeting the ER-phagy receptor FAM134B, leading to a pronounced increase in Salmonella burden after invasion. Salmonella prevents FAM134B oligomerization, which is required for efficient ER-phagy. FAM134B knock-out raises intracellular Salmonella number, while FAM134B activation reduces Salmonella burden. Additionally, we found that Salmonella targets FAM134B through the bacterial effector SopF to enhance intracellular survival through ER-phagy inhibition. Furthermore, FAM134B knock-out mice infected with Salmonella presented severe intestinal damage and increased bacterial burden. These results provide mechanistic insight into the interplay between ER-phagy and bacterial infection, highlighting a key role for FAM134B in innate immunity.

Indexed as

Bacterial ProteinsEndoplasmic ReticulumIntracellular Signaling Peptides and ProteinsMembrane ProteinsSalmonella InfectionsSalmonella typhimuriumAnimalsAutophagyFemaleHeLa CellsHost-Pathogen InteractionsHumansMiceMice, Inbred C57BLMice, KnockoutBacterial ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsRETREG1 protein, human

Identifiers

PMID40133256
PMCPMC11937434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.